Union Budget 2026 boosts India’s biopharma ambitions: USAIC
Washington, Feb 2 (IANS) The annual Union Budget sends a clear policy signal on biopharma and healthcare innovation, the USA India Chambers of Commerce (USAIC) said, citing new investments, expansion of clinical trial infrastructure, and steps toward global regulatory alignment.